跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DABIGATRÁN ETEXILATO STADA 150 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DABIGATRÁN ETEXILATO STADA 150 MG CAPSULAS DURAS EFG
Approved
STANDARD
DABIGATRÁN ETEXILATO STADA 150 MG CAPSULAS DURAS EFG
Laboratorio Stada S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 7, 2023
Approval ID
8b940887f631035e
Company
Laboratorio Stada S.L.
Type
Standard
Approval Details
Approval Id
8b940887f631035e
Drug Cima Aemps Name
DABIGATRÁN ETEXILATO STADA 150 MG CAPSULAS DURAS EFG
Register Number
89185
Holder Company Name
Laboratorio Stada S.L.
Marketing Company Name
Laboratorio Stada S.L.
Authorization Date
2023-12-07
Dosage Form
CÁPSULA DURA
Dose
150 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Laboratorio Stada S.L.
Active Ingredients
DABIGATRAN ETEXILATO
150 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 7, 2023
Approval ID
8b940887f631035e
Type
Standard
Back to CIMA-AEMPS Approvals
